Related Experiment Video
Updated: May 21, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
[Long term effectiveness of vaccination of Hepatitis A]
1Department of Health Statistics, West China School of Public Health, Sichuan University, Chengdu 610041, China.
Objective:
To develop a dynamic model of Hepatitis A transmission in order to predict the long-term effectiveness of Hepatitis A vaccination on 18 months old infants and 2 to 18 years old children.
Methods:
A dynamic model of HA (S-E-I-R-V) was developed using the software Berkeley-Madonna. The parameters required for the model derived from literature. A sensitivity analysis was performed to assess the stability of the model through changing parameters.
Results:
During the period of 2010 to 2030, the cumulative cases of Hepatitis A would reach 7.8 million with an incidence of 38.8 per 100,000 without vaccination. With 38% to 57% coverage of vaccination in children of 1.5-18 years old, the cumulative cases would decrease to 4.36-4.75 million with an incidence of 17.5-19.4 per 100,000. The vaccination was predicted to reduce 3.06-3.45 million Hepatitis A cases with an incidence reduction of 19.4-21.3 per 100,000. This suggests that Hepatitis A vaccination would achieve a 54% decrease in incidence of Hepatitis A. The sensitivity analysis showed that the coverage of vaccination had a significant impact on the incidence of Hepatitis A. By 2030, the incidence of Hepatitis A would decrease from 19.4 per 100,000 to 16.0 per 100,000 when the vaccination coverage increases from 38% to 90%.
Conclusion:
Hepatitis A vaccination can effectively prevent and control the incidence of Hepatitis A.
Related Concept Videos
Vaccinations
Hepatitis
Vaccines
Viral Hepatitis I: Introduction
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
